PMC3685362_01
Clinical course of patient 1. Timeline linear graph of platelet counts (solid line) and percentage of CD20 positive cells (dotted line), coinciding with rituximab (R) and dexamethasone (D) (arrows) and prednisone (bar) therapy
WO-17-20641-g001.jpg
PMC3685362_01_WO-17-20641-g001.jpg
F0001
Interestingly, a very low CD20 expression level was continuously observed throughout the treatment period (Fig. 1).
PMC3685362_02
Clinical course of patient 2. Timeline linear graph of platelet counts (solid line) and percentage of CD20 positive cells (dotted line), coinciding with rituximab (R) and dexamethasone (D) (arrows) and prednisone (bar) therapy
WO-17-20641-g002.jpg
PMC3685362_02_WO-17-20641-g002.jpg
F0002
Similar to the result of the previous case, her CD20 expression level was constantly low after treatment with rituximab (Fig. 2).